论文信息 - CRISPR/Cas9 as a therapeutic tool for triple negative breast cancer: from bench to clinics - 字舞流文

CRISPR/Cas9 as a therapeutic tool for triple negative breast cancer: from bench to clinics

D. Dayal | P. Tiwari | K. Chaubey | Chih-Wei Chiang | Rajni Dubey | L. Tsai | H. Singh | Sanjay Kumar | Tin-Hsien Ko | Mandeep Chouhan